| FN | ISI Export Format | | VR | 1.0 |
| PT |
J |
| AU |
Aitini, E
Sempreboni, A
Aleotti, P
Zamagni, D
Cavazzini, G
Barbieri, R
Cengarle, R
Rabbi, C
Pari, F
Vivorio, B |
| AF |
Aitini, Enrico
Sempreboni, Alessia
Aleotti, Paola
Zamagni, Donatella
Cavazzini, Giovanna
Barbieri, Roberto
Cengarle, Rita
Rabbi, Carla
Pari, Franca
Vivorio, Beatrice |
| TI |
Anxiety levels in cancer patients and "life sound" experience |
| SO |
TUMORI |
| AB |
Aims and background: For the hospitalized cancer patient, time takes on
a rhythm which is very different from the external reality. Based on
the idea that time represents a fundamental dimension of human
existence and is connected to future plans, time spent waiting and
memories, we carried out this experience entitled "Life Sound" project.
The objectives of the project were to experiment different and unusual
ways of spending time in hospital in order to improve the quality of
life of the hospitalized cancer patient, to help the patient adapt to
the hospital environment, to encourage awareness of self and to give a
different meaning to time spent in the hospital. In particular, we
evaluated the reduction in the levels of anxiety, in psychological
suffering and the improvement in communication.
Methods: We met with patients, family members, friends, volunteers and
department personnel (doctors, psychologists, nurses) in a room in the
Oncology and Hematology Department set aside specifically for
recreation activities such as having a cup of tea while listening to
music, talking, joking, listening to people's memories and celebrating
birthdays, anniversaries and other special days. The study, which
involved 109 patients, was carried out through the use of the
questionnaire STAI-Y distributed before and after the event.
Results: The results showed a statistically significant difference in
anxiety levels 2 hrs before participation (mean = 38.33) and 2 hrs
after participation (mean = 34.77) in the program. This variation was
also assessed based on gender, age, cancer stage, time since diagnosis
and performance status but did not result in any statistically
significant difference.
Conclusions: The "Life Sound" project encourages the emergence of
positive feelings, of a renewed willingness to invest in personal and
caring relationships, which are connected to the patient's ability to
face this illness, and the opening of new channels of communication
with family members and hospital staff. |
| SN |
0300-8916 |
| PD |
JAN-FEB |
| PY |
2007 |
| VL |
93 |
| IS |
1 |
| BP |
75 |
| EP |
77 |
| UT |
ISI:000247166900013 |
| ER |
|
| PT |
J |
| AU |
Badger, T
Segrin, C
Dorros, SM
Meek, P
Lopez, AM |
| AF |
Badger, Terry
Segrin, Chris
Dorros, Sybilla M.
Meek, Paula
Lopez, Ana Maria |
| TI |
Depression and anxiety in women with breast cancer and their partners |
| SO |
NURSING RESEARCH |
| AB |
Background: Psychosocial interventions can improve psychological
quality of life (symptoms of depression and anxiety) of both women with
breast cancer and their partners, but are not offered routinely to
women and their partners.
Objective: To test the. hypotheses that telephone-delivered
psychosocial interventions decrease depression and anxiety in women
with breast cancer and their partners.
Methods: The design of the study was a three-wave repeated measures
with a between-subjects factor (treatment group). Ninety-six women and
their 96 partners were assigned randomly to participate in one of three
different 6-week programs: (a) telephone interpersonal counseling
(TIP-C); (b) self-managed exercise; or (c) attention control (AC).
Results: The mixed-model analysis of variance for symptoms of
depression among women with breast cancer revealed women's depressive
symptom scores decreased over time in all groups. For anxiety, women's
symptoms of anxiety decreased in the TIP-C and exercise groups over
time, but not in the AC group. A parallel set of analyses was conducted
on partners' depression and anxiety data, Symptoms of depression and
anxiety among the partners decreased substantially over the course of
the investigation. Similar to the women, partners' symptoms of anxiety
decreased significantly in the TIP-C and exercise groups, but not in
the AC group.
Discussion: Findings from this study support that these
telephone-delivered psychosocial interventions were effective for
decreasing symptoms of depression and anxiety to improve psychological
quality of life when compared to an AC group. |
| SN |
0029-6562 |
| PD |
JAN-FEB |
| PY |
2007 |
| VL |
56 |
| IS |
1 |
| BP |
44 |
| EP |
53 |
| UT |
ISI:000247102400006 |
| ER |
|
| PT |
J |
| AU |
Dale, W
Hemmerich, J
Meltzer, D |
| AF |
Dale, William
Hemmerich, Joshua
Meltzer, David |
| TI |
Extending the validity of the Prostate Cancer (MAX-PC) Memorial Anxiety
Scale for at the time of prostate biopsy in a racially-mixed population |
| SO |
PSYCHO-ONCOLOGY |
| AB |
The Memorial Anxiety Scale for Prostate Cancer (MAX-PC) has been
validated for assessing men with prostate cancer for cancer-specific
anxiety. It was originally validated in a predominantly white
population. The MAX-PC Prostate Cancer Anxiety Subscale (MAX-PC-PCAS)
may be relevant for measuring cancer-specific anxiety in undiagnosed
men at risk for prostate cancer. We assess the validity of the
MAX-PC-PCAS at the time of prostate biopsy (n = 178). Questions
assessed socio-demographic information, health status,
patient-estimated risk of cancer, the Hospital Anxiety and Depression
Scale-Anxiety Subscale (HADS-A), and the MAX-PC-PCAS. The patients'
most recent PSA was recorded. Cronbach's alpha, inter-item
correlations, and Pearson correlations with both the HADS-A and
clinical variables were compared with the original validation sample.
Our sample was younger (63.1 vs 71.1 years), had a larger fraction of
African-Americans (43 vs 10%), and had higher PSAs. Cronbach's alpha
was equivalent (0.91 vs 0.90), median inter-item correlation was
equivalent (0.63 vs 0.61), and Pearson correlation with HADS-A was
higher (0.71 vs 0.57). Anxiety levels were not correlated with PSA
levels, and there were minor differences in the validation findings by
race. The validity of the MAX-PC-PCAS extends to men without cancer
undergoing biopsy and to African-Americans. Copyright (c) 2006 John
Wiley & Sons, Ltd. |
| SN |
1057-9249 |
| PD |
MAY |
| PY |
2007 |
| VL |
16 |
| IS |
5 |
| BP |
493 |
| EP |
498 |
| UT |
ISI:000246783300011 |
| ER |
|
| PT |
J |
| AU |
Midtqaard, J
Rorth, M
Steller, R
Tveteras, A
Andersen, C
Quist, M
Moller, T
Adamsen, L |
| AF |
Midtqaard, J.
Rorth, M.
Steller, R.
Tveteras, A.
Andersen, C.
Quist, M.
Moller, T.
Adamsen, L. |
| TI |
Exercise during cytostatic treatment: correlates of cancer patients'
self-reported anxiety and depression |
| SO |
EJC SUPPLEMENTS |
| SN |
1359-6349 |
| PD |
OCT |
| PY |
2005 |
| VL |
3 |
| IS |
2 |
| SU |
Suppl. S |
| BP |
369 |
| EP |
369 |
| UT |
ISI:000247564801434 |
| ER |
|
| PT |
J |
| AU |
Iconomou, G
Koutras, AK
Assimakopoulos, K
Mega, V
Viha, A
Iconomou, AV
Kalofonos, HP |
| AF |
Iconomou, G.
Koutras, A. K.
Assimakopoulos, K.
Mega, V.
Viha, A.
Iconomou, A. V.
Kalofonos, H. P. |
| TI |
Anxiety, depression and quality of life in cancer patients treated with
chemotherapy: a prospective examination |
| SO |
EJC SUPPLEMENTS |
| SN |
1359-6349 |
| PD |
OCT |
| PY |
2005 |
| VL |
3 |
| IS |
2 |
| SU |
Suppl. S |
| BP |
380 |
| EP |
381 |
| UT |
ISI:000247564801473 |
| ER |
|
| PT |
J |
| AU |
Reineke, A
Sowder, E
Gevirtz, R |
| AF |
Reineke, Anke
Sowder, Erik
Gevirtz, Richard |
| TI |
Effects of an inter-active biofeedback game on anxiety and pain in
children with cancer |
| SO |
BIOLOGICAL PSYCHOLOGY |
| SN |
0301-0511 |
| PD |
MAY |
| PY |
2007 |
| VL |
75 |
| IS |
2 |
| BP |
213 |
| EP |
214 |
| UT |
ISI:000246753200047 |
| ER |
|
| PT |
J |
| AU |
Cousson-Gelie, F
Bruchon-Schweitzer, M
Dilhuydy, JM
Jutand, MA |
| AF |
Cousson-Gelie, Florence
Bruchon-Schweitzer, Marilou
Dilhuydy, Jean Marie
Jutand, Marthe-Aline |
| TI |
Do anxiety, body image, social support and coping strategies predict
survival in breast cancer? A ten-year follow-up study |
| SO |
PSYCHOSOMATICS |
| AB |
A longitudinal study enrolled 75 women with primary breast cancer.
Before the confirmation of diagnosis, authors measured trait-anxiety
and body satisfaction. Three weeks after diagnosis, coping strategies
and state-anxiety were evaluated. The number of days of survival was
measured 10 years after diagnosis. In Cox proportional-hazards models
adjusting for severity of disease and age, high social support and low
state-anxiety predicted an increased risk of death from breast cancer.
A significant increased risk of death in women with low scores on the
Body Image Questionnaire appeared only in the univariate model. |
| SN |
0033-3182 |
| PD |
JUN |
| PY |
2007 |
| VL |
48 |
| IS |
3 |
| BP |
211 |
| EP |
216 |
| UT |
ISI:000246210400004 |
| ER |
|
| PT |
J |
| AU |
Trumbo, CW
McComas, KA
Kannaovakun, P |
| AF |
Trumbo, Craig W.
McComas, Katherine A.
Kannaovakun, Prathana |
| TI |
Cancer anxiety and the perception of risk in alarmed communities |
| SO |
RISK ANALYSIS |
| AB |
Cancer is a significant public health topic and is frequently a factor
in public reactions to environmental hazards. It may be reasonable to
suggest that a unique form of health anxiety exists-one specific to
cancer. In this article, we explore a measure of cancer anxiety that
has applicability to risk perception in the specific context of
communities that are alarmed over suspect cancer rates thought to be
associated with environmental hazards. A literature search was used to
identify survey questions previously used to measure cancer worry,
fear, anxiety, etc. A list of 24 items was employed in a mail survey
sent to 30 communities in which cancer rates were under investigation
(part of a broader study). An analysis of the dataset of 1,111
responses yields two versions of a cancer anxiety scale: one an
additive combination of 21 items (alpha= 0.77) and the other a
two-factor model consisting of nine- and four-item subscales (alpha =
0.74 and 0.69). The resulting scales are evaluated for their ability to
predict perception of risk from the environmental hazards in these
cases. Controlling for age, sex, and cancer status, the scales explain
between 2% and 10% of risk perception (full R-2 values ranging from
0.17 to 0.24). Given the range of concepts required to model risk
perception, we conclude that this measure of cancer anxiety is
sufficiently reliable and robust to be recommended for use in
circumstances involving hazards associated with cancer. Other uses and
further development of the measure are discussed. |
| SN |
0272-4332 |
| PD |
APR |
| PY |
2007 |
| VL |
27 |
| IS |
2 |
| BP |
337 |
| EP |
350 |
| UT |
ISI:000246625600007 |
| ER |
|
| PT |
J |
| AU |
Tagay, VS
Senf, W
Schopper, N
Mewes, R
Bockisch, A
Gorges, R |
| AF |
Tagay, Von Sefik
Senf, Wolfgang
Schoepper, Nicole
Mewes, Ricarda
Bockisch, Andreas
Goerges, Rainer |
| TI |
Protective factors for anxiety and depression in thyroid cancer patients |
| SO |
ZEITSCHRIFT FUR PSYCHOSOMATISCHE MEDIZIN UND PSYCHOTHERAPIE |
| AB |
Objectives: Depression and anxiety are the most common mental symptoms
in patients with thyroid cancer (DTC) and have an important influence
on the quality of life. The aim of the current study was to identify
protective factors of depression and anxiety in DTC patients.
Methods: In a cross-sectional study 230 DTC patients were examined with
Hospital Anxiety and Depression Scale (HADS-D), the Sense of Coherence
Scale (SOC-13) and the Questionnaire of Social Support (F-SOZU).
Results: Depression correlated highly significantly with anxiety (r =
.633, p = 0,001). Social support and sense of coherence correlated
highly significantly negative with depression as well as with anxiety
(both p <= 0,001). Although still significant, the correlation between
age and anxiety was lower (r = -19; p <= 0,005). The TSH level as an
indicator of hypothyreodism did not correlate with depression or with
anxiety on a significant statistical level. Furthermore, variables such
as education, religiosity and elapsed time interval since initial
diagnosis were not correlated with depression and anxiety.
Discussion: Our results support the thesis that low social support and
low sense of coherence enhance vulnerability to depressive and anxiety
symptoms. |
| SN |
1438-3608 |
| PY |
2007 |
| VL |
53 |
| IS |
1 |
| BP |
62 |
| EP |
74 |
| UT |
ISI:000244928300007 |
| ER |
|
| PT |
J |
| AU |
Sharp, DM
Walker, AA
Walker, MB
Walker, LG |
| AF |
Sharp, D. M.
Walker, A. A.
Walker, M. B.
Walker, L. G. |
| TI |
Are high levels of clinically significant anxiety and depression
inevitable in the six months following the diagnosis of early breast
cancer? |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
MAR |
| PY |
2007 |
| VL |
16 |
| IS |
3 |
| BP |
272 |
| EP |
273 |
| UT |
ISI:000244976700041 |
| ER |
|
| PT |
J |
| AU |
Greer, J
Temel, J
Pirl, W
Lynch, T |
| AF |
Greer, J.
Temel, J.
Pirl, W.
Lynch, T. |
| TI |
Anxiety, quality of life and chemotherapy adherence among patients with
advanced non-small cell lung cancer |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
MAR |
| PY |
2007 |
| VL |
16 |
| IS |
3 |
| SU |
Suppl. S |
| BP |
S13 |
| EP |
S13 |
| UT |
ISI:000245044900023 |
| ER |
|
| PT |
J |
| AU |
Zhang, A
Cooper, G |
| AF |
Zhang, A.
Cooper, G. |
| TI |
Recognition of depression and anxiety among colorectal cancer patients |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
MAR |
| PY |
2007 |
| VL |
16 |
| IS |
3 |
| SU |
Suppl. S |
| BP |
S23 |
| EP |
S24 |
| UT |
ISI:000245044900042 |
| ER |
|
| PT |
J |
| AU |
BrintzenhofeSzoc, KM
Levin, TT
Li, Y
Zabora, J |
| AF |
BrintzenhofeSzoc, K. M.
Levin, T. T.
Li, Y.
Zabora, J. |
| TI |
The prevalence of mixed anxiety-depression by cancer type |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
MAR |
| PY |
2007 |
| VL |
16 |
| IS |
3 |
| SU |
Suppl. S |
| BP |
S31 |
| EP |
S32 |
| UT |
ISI:000245044900057 |
| ER |
|
| PT |
J |
| AU |
Doyle, K
Fitzgibbons, L
Rollins, P
Stringer, CA |
| AF |
Doyle, K.
Fitzgibbons, L.
Rollins, P.
Stringer, C. A. |
| TI |
Changes in depression, anxiety and psychosocial adjustment to illness
following an individual intervention for women with advanced stage
ovarian cancer |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
MAR |
| PY |
2007 |
| VL |
16 |
| IS |
3 |
| SU |
Suppl. S |
| BP |
S37 |
| EP |
S37 |
| UT |
ISI:000245044900068 |
| ER |
|
| PT |
J |
| AU |
West, L
Bauer-Wu, S
Liem, J
Powell, M |
| AF |
West, L.
Bauer-Wu, S.
Liem, J.
Powell, M. |
| TI |
Factors associated with anxiety and depression in young women recently
diagnosed with breast cancer |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
MAR |
| PY |
2007 |
| VL |
16 |
| IS |
3 |
| SU |
Suppl. S |
| BP |
S92 |
| EP |
S93 |
| UT |
ISI:000245044900178 |
| ER |
|
| PT |
J |
| AU |
Pandey, M
Sarita, G
Devi, N
Thomas, B
Hussain, BM
Krishnan, R |
| AF |
Pandey, M.
Sarita, G.
Devi, N.
Thomas, B.
Hussain, B. M.
Krishnan, R. |
| TI |
Distress, anxiety and depression in cancer patients undergoing
chemotherapy |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
MAR |
| PY |
2007 |
| VL |
16 |
| IS |
3 |
| SU |
Suppl. S |
| BP |
S98 |
| EP |
S98 |
| UT |
ISI:000245044900189 |
| ER |
|
| PT |
J |
| AU |
Pressley, Z
DeLong, L
Curiel-Lewandrowski, C
Chen, S |
| AF |
Pressley, Zakiya
DeLong, Laura
Curiel-Lewandrowski, Clara
Chen, Suephy |
| TI |
Quality of life and cancer anxiety impact of total body digital
photography in patients with atypical mole syndrome |
| SO |
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY |
| SN |
0190-9622 |
| PD |
FEB |
| PY |
2007 |
| VL |
56 |
| IS |
2 |
| SU |
Suppl. S |
| BP |
AB144 |
| EP |
AB144 |
| UT |
ISI:000243972801116 |
| ER |
|
| PT |
J |
| AU |
Chauhan, D
Sharpe, L
Clarke, S
Thewes, B
Rickard, J |
| AF |
Chauhan, D.
Sharpe, L.
Clarke, S.
Thewes, B.
Rickard, J. |
| TI |
Using different screening modalities to assess for anxiety and
depression amongst cancer patients |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
OCT |
| PY |
2006 |
| VL |
15 |
| IS |
2 |
| SU |
Suppl. S |
| BP |
S105 |
| EP |
S106 |
| UT |
ISI:000242413900251 |
| ER |
|
| PT |
J |
| AU |
Alvarado, MC |
| AF |
Alvarado, M. C. |
| TI |
Anxiety in children with cancer and their parents |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
OCT |
| PY |
2006 |
| VL |
15 |
| IS |
2 |
| SU |
Suppl. S |
| BP |
S157 |
| EP |
S157 |
| UT |
ISI:000242413900370 |
| ER |
|
| PT |
J |
| AU |
Grassi, L
Sabato, S
Rossi, E
Marmai, L
Biancosino, B
Gatti, M |
| AF |
Grassi, L.
Sabato, S.
Rossi, E.
Marmai, L.
Biancosino, B.
Gatti, M. |
| TI |
Depressive and anxiety disorders among cancer patients: Screening
methods hy using the distress thermometer compared to the ICD-10 |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
OCT |
| PY |
2006 |
| VL |
15 |
| IS |
2 |
| SU |
Suppl. S |
| BP |
S162 |
| EP |
S162 |
| UT |
ISI:000242413900382 |
| ER |
|
| PT |
J |
| AU |
Cankurtaran, ES
Ozalp, E
Soygur, H
Turhan, L |
| AF |
Cankurtaran, E. S.
Ozalp, E.
Soygur, H.
Turhan, L. |
| TI |
The effect of mirtazapine on depression, anxiety symptoms and quality
of life in cancer patients |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
OCT |
| PY |
2006 |
| VL |
15 |
| IS |
2 |
| SU |
Suppl. S |
| BP |
S192 |
| EP |
S193 |
| UT |
ISI:000242413900452 |
| ER |
|
| PT |
J |
| AU |
Ciaramella, A
Lucente, F
Paroli, M
Poli, P |
| AF |
Ciaramella, A.
Lucente, F.
Paroli, M.
Poli, P. |
| TI |
Differences in pain perception between patients with and without
cancer. Role of anxiety and depression |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
OCT |
| PY |
2006 |
| VL |
15 |
| IS |
2 |
| SU |
Suppl. S |
| BP |
S200 |
| EP |
S201 |
| UT |
ISI:000242413900471 |
| ER |
|
| PT |
J |
| AU |
Cousson-Gelie, F
Bruchon-Schweitzer, M
Dilhuydy, JM
Jutand, MA |
| AF |
Cousson-Gelie, F.
Bruchon-Schweitzer, M.
Dilhuydy, J. M.
Jutand, M. A. |
| TI |
Impact of social support, anxiety and coping on survival after breast
cancer: A ten year followup study |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
OCT |
| PY |
2006 |
| VL |
15 |
| IS |
2 |
| SU |
Suppl. S |
| BP |
S213 |
| EP |
S214 |
| UT |
ISI:000242413900503 |
| ER |
|
| PT |
J |
| AU |
Cross, LJ
Clover, KA
Adams, CA
Utram, SC
Ponman, LK |
| AF |
Cross, L. J.
Clover, K. A.
Adams, C. A.
Utram, S. C.
Ponman, L. K. |
| TI |
A multidisciplinary pilot study to screen for anxiety and distress in
cancer patients when a head immobilization device is used for
radiotherapy treatment |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
OCT |
| PY |
2006 |
| VL |
15 |
| IS |
2 |
| SU |
Suppl. S |
| BP |
S214 |
| EP |
S214 |
| UT |
ISI:000242413900504 |
| ER |
|
| PT |
J |
| AU |
Geinitz, H
Thamm, R
Keller, M
Molls, M
Zimmermann, F |
| AF |
Geinitz, H.
Thamm, R.
Keller, M.
Molls, M.
Zimmermann, F. |
| TI |
Longitudinal evaluation of anxiety, depression and quality of life in
patients with conformal radiation therapy (CRT) for prostate cancer |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
OCT |
| PY |
2006 |
| VL |
15 |
| IS |
2 |
| SU |
Suppl. S |
| BP |
S246 |
| EP |
S247 |
| UT |
ISI:000242413901025 |
| ER |
|
| PT |
J |
| AU |
Gorayeb, R
Matthes, HTZ
Andrade, JM |
| AF |
Gorayeb, R.
Matthes, H. T. Z.
Andrade, J. M. |
| TI |
Anxiety, depression and level of knowledge in breast and gynaecological
cancer patients in a public University Hospital in Brazil |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
OCT |
| PY |
2006 |
| VL |
15 |
| IS |
2 |
| SU |
Suppl. S |
| BP |
S252 |
| EP |
S253 |
| UT |
ISI:000242413901039 |
| ER |
|
| PT |
J |
| AU |
Lopez Soler, C
Hernandez, S
Fernandez, V |
| AF |
Lopez Soler, C.
Hernandez, S.
Fernandez, V |
| TI |
Affective and anxiety problems of childhood cancer |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
OCT |
| PY |
2006 |
| VL |
15 |
| IS |
2 |
| SU |
Suppl. S |
| BP |
S259 |
| EP |
S260 |
| UT |
ISI:000242413901056 |
| ER |
|
| PT |
J |
| AU |
Helmes, AW
Vogel, BA
Bengel, J |
| AF |
Helmes, A. W.
Vogel, B. A.
Bengel, J. |
| TI |
Predictors of anxiety and depression in breast cancer patients:
Physician-patient communication or coping? |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
OCT |
| PY |
2006 |
| VL |
15 |
| IS |
2 |
| SU |
Suppl. S |
| BP |
S264 |
| EP |
S265 |
| UT |
ISI:000242413901067 |
| ER |
|
| PT |
J |
| AU |
Hill, KA
Warner, E
Esplen, MJ
Butler, K
Bieenwald, R |
| AF |
Hill, K. A.
Warner, E.
Esplen, M. J.
Butler, K.
Bieenwald, R. |
| TI |
Distress and breast cancer anxiety among BRCA mutation carriers
participating in MRI-based screening |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
OCT |
| PY |
2006 |
| VL |
15 |
| IS |
2 |
| SU |
Suppl. S |
| BP |
S267 |
| EP |
S267 |
| UT |
ISI:000242413901073 |
| ER |
|
| PT |
J |
| AU |
Yamashita, M
Saeki, T
Inoue, S
Mantani, T
Okamura, H |
| AF |
Yamashita, M.
Saeki, T.
Inoue, S.
Mantani, T.
Okamura, H. |
| TI |
Family functioning as a predictor of depression and anxiety in breast
cancer survivors: 3-year prospective study |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
OCT |
| PY |
2006 |
| VL |
15 |
| IS |
2 |
| SU |
Suppl. S |
| BP |
S279 |
| EP |
S279 |
| UT |
ISI:000242413901101 |
| ER |
|
| PT |
J |
| AU |
Lienard, A
Merckaert, I
Libert, Y
Marchal, S
Razavi, D |
| AF |
Lienard, A.
Merckaert, I
Libert, Y.
Marchal, S.
Razavi, D. |
| TI |
Factors that influence cancer patients' anxiety following a medical
consultation. Impact of a communication skills training program for
physicians |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
OCT |
| PY |
2006 |
| VL |
15 |
| IS |
2 |
| SU |
Suppl. S |
| BP |
S308 |
| EP |
S308 |
| UT |
ISI:000242413901169 |
| ER |
|
| PT |
J |
| AU |
Mehnert, A
Lehmann, C
Koch, U
Schulte, T |
| AF |
Mehnert, A.
Lehmann, C.
Koch, U.
Schulte, T. |
| TI |
Presence of prostate cancer related anxiety and psychosocial distress
in patients during rehabilitative follow-up care |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
OCT |
| PY |
2006 |
| VL |
15 |
| IS |
2 |
| SU |
Suppl. S |
| BP |
S322 |
| EP |
S322 |
| UT |
ISI:000242413901201 |
| ER |
|
| PT |
J |
| AU |
Neumann, M
Pfaff, H |
| AF |
Neumann, M.
Pfaff, H. |
| TI |
Sex and empathy of physicians and affection of nurses can improve
patients' anxiety level in first months after cancer diagnosis - An
explorative, retrospective study in patients with bronchial,
oesophagus, colorectal, breast, prostate and skin cancer |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
OCT |
| PY |
2006 |
| VL |
15 |
| IS |
2 |
| SU |
Suppl. S |
| BP |
S346 |
| EP |
S347 |
| UT |
ISI:000242413901258 |
| ER |
|
| PT |
J |
| AU |
Pandey, M
Devi, N
Ramdas, K
Krishnan, R
Thomas, BC |
| AF |
Pandey, M.
Devi, N.
Ramdas, K.
Krishnan, R.
Thomas, B. C. |
| TI |
Distress, anxiety and depression in patients with head neck cancer
undergoing treatment with curative intent |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
OCT |
| PY |
2006 |
| VL |
15 |
| IS |
2 |
| SU |
Suppl. S |
| BP |
S359 |
| EP |
S359 |
| UT |
ISI:000242413901288 |
| ER |
|
| PT |
J |
| AU |
Pikunas, JDKA
Springer, C |
| AF |
Pikunas, J. D. K. A.
Springer, C. |
| TI |
Anxiety and depression at the point of cancer diagnosis and its
relationship to coping |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
OCT |
| PY |
2006 |
| VL |
15 |
| IS |
2 |
| SU |
Suppl. S |
| BP |
S369 |
| EP |
S369 |
| UT |
ISI:000242413901312 |
| ER |
|
| PT |
J |
| AU |
Reis, JC
Lucas, HM |
| AF |
Reis, J. C.
Lucas, H. M. |
| TI |
Illness representation and levels of quality of life, anxiety and
depression in patients with prostate cancer |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
OCT |
| PY |
2006 |
| VL |
15 |
| IS |
2 |
| SU |
Suppl. S |
| BP |
S380 |
| EP |
S380 |
| UT |
ISI:000242413901339 |
| ER |
|
| PT |
J |
| AU |
Schillani, G
Malagoli, M
Tuveri, G
Giraldi, T |
| AF |
Schillani, G.
Malagoli, M.
Tuveri, G.
Giraldi, T. |
| TI |
Anxiety, depression and mental adaptation in cancer patients - Role of
serotonin transporter and monoamine oxidase polymorphism |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
OCT |
| PY |
2006 |
| VL |
15 |
| IS |
2 |
| SU |
Suppl. S |
| BP |
S399 |
| EP |
S399 |
| UT |
ISI:000242413901384 |
| ER |
|
| PT |
J |
| AU |
Snoj, Z
Primic Aakelj, M
Milan, L |
| AF |
Snoj, Z.
Primic Aakelj, M.
Milan, L. |
| TI |
Depression and anxiety in Slovenian breast cancer patients |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
OCT |
| PY |
2006 |
| VL |
15 |
| IS |
2 |
| SU |
Suppl. S |
| BP |
S416 |
| EP |
S416 |
| UT |
ISI:000242413901424 |
| ER |
|
| PT |
J |
| AU |
Walker, MB
Walker, AA
Walker, LG
Sharp, DM |
| AF |
Walker, M. B.
Walker, A. A.
Walker, L. G.
Sharp, D. M. |
| TI |
What happens to anxiety and depression in women with early breast
cancer accessing an integrated oncology health service? |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
OCT |
| PY |
2006 |
| VL |
15 |
| IS |
2 |
| SU |
Suppl. S |
| BP |
S452 |
| EP |
S452 |
| UT |
ISI:000242413901508 |
| ER |
|
| PT |
J |
| AU |
Stephenson, NLN
Swanson, M
Dalton, J
Keefe, FJ
Engelke, M |
| AF |
Stephenson, Nancy L. N.
Swanson, Melvin
Dalton, JoAnn
Keefe, Francis J.
Engelke, Martha |
| TI |
Partner-delivered reflexology: Effects on cancer pain and anxiety (vol
34, pg 127, 2007) |
| SO |
ONCOLOGY NURSING FORUM |
| SN |
0190-535X |
| PD |
MAR |
| PY |
2007 |
| VL |
34 |
| IS |
2 |
| BP |
280 |
| EP |
280 |
| UT |
ISI:000244949700012 |
| ER |
|
| PT |
J |
| AU |
Frick, E
Tyroller, M
Panzer, M |
| AF |
Frick, E.
Tyroller, M.
Panzer, M. |
| TI |
Anxiety, depression and quality of life of cancer patients undergoing
radiation therapy: a cross-sectional study in a community hospital
outpatient centre |
| SO |
EUROPEAN JOURNAL OF CANCER CARE |
| AB |
The purpose of the present study is to determine the impact of illness
characteristics and psychopathological comorbidity on the quality of
life (QoL) of radio-oncological patients in health-related and
individual dimensions. Sixty-three of 93 eligible patients (40 women
and 23 men) were included in the study during their radiation therapy
visit to an outpatient centre annexed to a community hospital in
Southern Bavaria, Germany. In a semi-structured interview, we elicited
individually relevant life domains rated by the patients according to
the 'Schedule for the Evaluation of Individual Quality of Life - Direct
Weighting'. In addition, the participants completed the 'European
Organization for Research and Treatment of Cancer (EORTC) QoL
Questionnaire Core 30' and the 'Hospital Anxiety and Depression Scale'.
We also assessed the demand for psychotherapy and utilization of
psycho-oncological services. In total, 9.5% of the examined patients
suffer from clinically relevant anxiety and/or depression [total
Hospital Anxiety and Depression Scale (HADS) score > 19]. There was a
weak positive correlation between Karnofsky's Performance Status and
QoL. Anxiety and depression were significantly correlated with impaired
QoL, especially with impaired individual QoL. There was no association
between psychopathological comorbidity and the requirement for
psycho-oncological support. Conversely, patients who report
difficulties in accepting help had a significantly lower QoL.
Psychopathological comorbidity has a considerable influence on QoL of
patients undergoing radiotherapy. Measuring the individual QoL appears
as an adapted needs assessment and helps the psychotherapist in
focusing on the patient's problems and desires. Furthermore, the
patient's QoL is a main target in providing or planning mental health
care in non-university oncological services. |
| SN |
0961-5423 |
| PD |
MAR |
| PY |
2007 |
| VL |
16 |
| IS |
2 |
| BP |
130 |
| EP |
136 |
| UT |
ISI:000244942500004 |
| ER |
|
| PT |
J |
| AU |
Takahashi, K
Ida, I
Kumano, H
Oshima, A
Yuuki, N
Aihara, M
Sato, H
Majima, T
Yonemura, K
Fukuda, M
Oriuchi, N
Amanuma, M
Endo, K
Matsuda, H
Mikuni, M |
| AF |
Takahashi, K.
Ida, I.
Kumano, H.
Oshima, A.
Yuuki, N.
Aihara, M.
Sato, H.
Majima, T.
Yonemura, K.
Fukuda, M.
Oriuchi, N.
Amanuma, M.
Endo, K.
Matsuda, H.
Mikuni, M. |
| TI |
Brain metabolic changes associated with the onset of depression and
anxiety in cancer patients |
| SO |
PSYCHIATRY AND CLINICAL NEUROSCIENCES |
| SN |
1323-1316 |
| PD |
APR |
| PY |
2007 |
| VL |
61 |
| IS |
2 |
| BP |
S7 |
| EP |
S7 |
| UT |
ISI:000244600300040 |
| ER |
|
| PT |
J |
| AU |
Stephenson, NLN
Swanson, M
Dalton, J
Keefe, FJ
Engelke, M |
| AF |
Stephenson, Nancy L. N.
Swanson, Melvin
Dalton, JoAnn
Keefe, Frances J.
Engelke, Martha |
| TI |
Partner-delivered reflexology: Effects on cancer pain and anxiety |
| SO |
ONCOLOGY NURSING FORUM |
| AB |
Purpose/Objectives: To compare the effects of partner-delivered foot
reflexology and usual care plus attention on patients' perceived pain
and anxiety.
Design: The experimental pretest/post-test design included
patient-partner dyads randomly assigned to an experimental or control
group.
Setting: Four hospitals in the southeastern United States.
Sample: 42 experimental and 44 control subjects comprised 86 dyads of
patients with metastatic cancer and their partners, representing 16
different types of cancer; 23% of patients had lung cancer, followed by
breast, colorectal, and head and neck cancer and lymphoma. The subjects
had a mean age of 58.3 years, 51% were female, 66% had a high school
education or less, and 58% were Caucasian, 40% were African American,
and 1% were Filipino.
Methods: The intervention included a 15-to 30-minute teaching session
on foot reflexology to the partner by a certified reflexologist, an
optional 15-to 30-minute foot reflexology session for the partner, and
a 30-minute, partner-delivered foot reflexology intervention for the
patient. The control group received a 30-minute reading session from
their partners.
Main Research Variables: Pain and anxiety. Findings: Following the
initial partner-delivered foot reflexology, patients experienced a
significant decrease in pain intensity and anxiety.
Conclusions: A nurse reflexologist taught partners how to perform
reflexology on patients with metastatic cancer pain in the hospital,
resulting in an immediate decrease in pain intensity and anxiety;
minimal changes were seen in the control group, who received usual care
plus attention.
Implications for Nursing: Hospitals could have qualified professionals
offer reflexology as a complementary therapy and teach interested
partners the modality. |
| SN |
0190-535X |
| PD |
JAN |
| PY |
2007 |
| VL |
34 |
| IS |
1 |
| BP |
127 |
| EP |
132 |
| UT |
ISI:000243441000022 |
| ER |
|
| PT |
J |
| AU |
Schoen, M
Roth, A
Nelson, C
Bhaskaran, V |
| AF |
Schoen, Mary
Roth, Andrew
Nelson, Christian
Bhaskaran, Vidhya |
| TI |
Anxiety and depression in prostate cancer survivors, postprostatectomy. |
| SO |
ONCOLOGY NURSING FORUM |
| SN |
0190-535X |
| PD |
JAN |
| PY |
2007 |
| VL |
34 |
| IS |
1 |
| BP |
172 |
| EP |
173 |
| UT |
ISI:000243441000041 |
| ER |
|
| PT |
J |
| AU |
Wilson, KG
Chochinov, HM
Skirko, MG
Allard, P
Chary, S
Gagnon, PR
Macmillan, K
De Luca, M
O'Shea, F
Kuhl, D
Fainsinger, RL
Clinch, JJ |
| AF |
Wilson, Keith G.
Chochinov, Harvey Max
Skirko, Merika Graham
Allard, Pierre
Chary, Srini
Gagnon, Pierre R.
Macmillan, Karen
De Luca, Marina
O'Shea, Fiona
Kuhl, David
Fainsinger, Robin L.
Clinch, Jennifer J. |
| TI |
Depression and anxiety disorders in palliative cancer care |
| SO |
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT |
| AB |
Depression and anxiety disorders are thought to be common in palliative
cancer care, but there is inconsistent evidence regarding their
relevance for other aspects of quality of life. In the Canadian
National Palliative Care Survey, semi-structured interviews assessing
depression and anxiety disorders were administered to 381 patients who
were receiving palliative care for cancer. There were 212 women and 169
men, with a median survival of, 63 days. We found that 93 participants
(24.4 %, 95 % confidence interval= 20.2-29.0) fulfilled Diagnostic and
Statistical Manual of Mental Disorders, Fourth Edition diagnostic
criteria for at least one anxiety or depressive disorder (20.7%
prevalence of depressive disorders, 13.9% prevalence of anxiety
disorders). The most frequent individual diagnosis was major depression
(13.1%, 95% confidence interval = 9.9-16.9). Comorbidity was common,
with 10.2% of participants meeting criteria for more than one disorder.
Those diagnosed with a disorder were significantly younger than other
participants (P = 0.002). They also had lower performance status (P =
0.017), smaller social networks (P = 0.008), and less participation in
organized religious services (P = 0.007). In addition, they reported
more severe distress on 14 of 18 physical symptoms, social concerns,
and existential issues. Of those with a disorder, 39.8% were being
treated, with antidepressant medication, and 66.7% bad been prescribed
a benzodiazepine. In conclusion, it appears that, de/nession, and
anxiety disorders are indeed common among patients receiving palliative
care. The disorders contribute to a greatly diminished quality of life
among people who are dying of cancer. |
| SN |
0885-3924 |
| PD |
FEB |
| PY |
2007 |
| VL |
33 |
| IS |
2 |
| BP |
118 |
| EP |
129 |
| UT |
ISI:000244268800004 |
| ER |
|
| PT |
J |
| AU |
Andrews, A
Rosenbaum, EH
Garlan, R
Siegal, A
Hirschberger, N
Butler, LD
Esserman, L
Spiegel, D |
| AF |
Andrews, A.
Rosenbaum, E. H.
Garlan, R.
Siegal, A.
Hirschberger, N.
Butler, L. D.
Esserman, L.
Spiegel, D. |
| TI |
The life tape project: a psychosocial intervention for cancer patients
and their families to increase communication and support, and reduce
isolation and existential anxiety. |
| SO |
BREAST CANCER RESEARCH AND TREATMENT |
| SN |
0167-6806 |
| PY |
2006 |
| VL |
100 |
| SU |
Suppl. 1 |
| BP |
S99 |
| EP |
S99 |
| UT |
ISI:000242047100287 |
| ER |
|
| PT |
J |
| AU |
Wilkinson, SM
Love, SB
Westcombe, AM
Gambles, MA
Burgess, CC
Cargill, A
Young, T
Maher, EJ
Ramirez, AJ |
| AF |
Wilkinson, Susie M.
Love, Sharon B.
Westcombe, Alex M.
Gambles, Maureen A.
Burgess, Caroline C.
Cargill, Anna
Young, Teresa
Maher, E. Jane
Ramirez, Amanda J. |
| TI |
Effectiveness of aromatherapy massage in the management of anxiety and
depression in patients with cancer: A multicenter randomized controlled
trial |
| SO |
JOURNAL OF CLINICAL ONCOLOGY |
| AB |
Purpose
To test the effectiveness of supplementing usual supportive care with
aromatherapy massage in the management of anxiety and depression in
cancer patients through a pragmatic two-arm randomized controlled trial
in four United Kingdom cancer centers and a hospice.
Patients and Methods
Two hundred eighty-eight cancer patients, referred to complementary
therapy services with clinical anxiety and/or depression, were
allocated randomly to a course of aromatherapy massage or usual
supportive care alone.
Results
Patients who received aromatherapy massage had no significant
improvement in clinical anxiety and/or depression compared with those
receiving usual care at 10 weeks postrandomization ( odds ratio [ OR],
1.3; 95% CI, 0.9 to 1.7; P =.1), but did at 6 weeks postrandomization (
OR, 1.4; 95% CI, 1.1 to 1.9; P =.01). Patients receiving aromatherapy
massage also described greater improvement in self-reported anxiety at
both 6 and 10 weeks postrandomization ( OR, 3.4; 95% CI, 0.2 to 6.7; P
=.04 and OR, 3.4; 95% CI, 0.2 to 6.6; P =.04), respectively.
Conclusion
Aromatherapy massage does not appear to confer benefit on cancer
patients' anxiety and/or depression in the long-term, but is associated
with clinically important benefit up to 2 weeks after the intervention. |
| SN |
0732-183X |
| PD |
FEB 10 |
| PY |
2007 |
| VL |
25 |
| IS |
5 |
| BP |
532 |
| EP |
539 |
| UT |
ISI:000244176000012 |
| ER |
|
| PT |
J |
| AU |
Filipovic, BR
Filipovic, BF
Kerkez, M
Milinic, N
Randelovic, T |
| AF |
Filipovic, Branislav R.
Filipovic, Branka F.
Kerkez, Mirko
Milinic, Nikola
Randelovic, Tomislav |
| TI |
Depression and anxiety levels in therapy-naive patients with
inflammatory bowel disease and cancer of the colon |
| SO |
WORLD JOURNAL OF GASTROENTEROLOGY |
| AB |
AIM: To assess whether depression and anxiety are more expressed in
patients with the first episode of inflammatory bowel disease (IBD)
than in individuals with newly discovered cancer of the colon (CCa).
METHODS: A total of 32 patients with IBD including 13 males and 19
females, aged 27 to 74, and 30 patients with CCa including 20 males and
10 females, aged 39-78, underwent a structured interview, which
comprised Hamilton's Depression Rating Inventory, Hamilton's Anxiety
Rating Inventory and Paykel's Stressful Events Rating Scale.
RESULTS: Patients of the IBD group expressed both depression and
anxiety. Depressive mood, sense of guilt, psychomotor retardation and
somatic anxiety were also more pronounced in IBD patients. The
discriminant function analysis revealed the total depressive score was
of high importance for the classification of a newly diagnosed patient
into one of the groups.
CONCLUSION: Newly diagnosed patients with IBD have higher levels of
depression and anxiety. Moreover, a psychiatrist in the treatment team
is advisable from the beginning. (c) 2007 The WJG Press. All rights
reserved. |
| SN |
1007-9327 |
| PD |
JAN 21 |
| PY |
2007 |
| VL |
13 |
| IS |
3 |
| BP |
438 |
| EP |
443 |
| UT |
ISI:000243613900017 |
| ER |
|
| PT |
J |
| AU |
Bekher, OA
Slonimskaya, EM
Kupriyanova, IE |
| AF |
Bekher, O. A.
Slonimskaya, E. M.
Kupriyanova, I. E. |
| TI |
Level of anxiety in breast cancer women |
| SO |
NEURO-ONCOLOGY |
| SN |
1522-8517 |
| PD |
OCT |
| PY |
2006 |
| VL |
8 |
| IS |
4 |
| BP |
360 |
| EP |
361 |
| UT |
ISI:000240877300271 |
| ER |
|
| PT |
J |
| AU |
Tsutsumi, S
Yamaki, S
Yamaguchi, S
Asao, T
Kuwano, H |
| AF |
Tsutsumi, Soichi
Yamaki, Sayaka
Yamaguchi, Satoru
Asao, Takayuki
Kuwano, Hiroyuki |
| TI |
Anxiety in outpatients receiving chemotherapy for solid cancer |
| SO |
HEPATO-GASTROENTEROLOGY |
| AB |
Background/Aims: We conducted this prospective study to assess the
anxiety in outpatients receiving chemotherapy for solid cancers.
Methodology: Patients were eligible if they were receiving chemotherapy
for solid cancer in an outpatient setting, had a life expectancy of
more than 6 months, and were able to complete self-administered
questionnaires. The State-Trait Anxiety Inventory (STAI) was used to
measure the anxiety levels.
Results: From January to December 2004, 119 patients were recruited,
and, of these, 114 completed the questionnaires. Their median age was
60.6 years, and the male-to-female ratio was 1.04:1. Of the 114
patients, 36 had breast cancer, 35, colorectal cancer, 23, gastric
cancer, 8, esophageal cancer, 5, non-small-cell cancer, 4, pancreatic
cancer, and 3, liver cancer. The state- and trait-anxiety levels were
higher for women (p=0.019). Age did not influence the trait-anxiety
level, but the state-anxiety levels of younger patients were higher.
The periods of chemotherapy raised the state and trait-anxiety levels
(p=0.023 and 0.015, respectively). No statistically significant
differences were observed according to the type of cancer.
Conclusions: The anxiety levels of outpatients with solid cancer
receiving chemotherapy were significantly high. Having access to such
information will help oncologists provide appropriate support to their
patients. |
| SN |
0172-6390 |
| PD |
NOV-DEC |
| PY |
2006 |
| VL |
53 |
| IS |
72 |
| BP |
828 |
| EP |
830 |
| UT |
ISI:000242306400005 |
| ER |
|
| PT |
J |
| AU |
Dell'Agostino, K
Fiumano, M
Fusco, O
Malugani, F
Berardi, E
Menatti, E
Bartolini, A |
| AF |
Dell'Agostino, K.
Fiumano, M.
Fusco, O.
Malugani, F.
Berardi, E.
Menatti, E.
Bartolini, A. |
| TI |
Anxiety/depression screening in cancer patient by Zung evaluation form |
| SO |
ANNALS OF ONCOLOGY |
| SN |
0923-7534 |
| PY |
2006 |
| VL |
17 |
| SU |
Suppl. 11 |
| BP |
XI34 |
| EP |
XI34 |
| UT |
ISI:000242379800128 |
| ER |
|
| PT |
J |
| AU |
Seo, PH
Sloane, R
Ingram, SS
Misra, D
Clipp, EC
Montana, GS
Cohen, HJ |
| AF |
Seo, P. H.
Sloane, R.
Ingram, S. S.
Misra, D.
Clipp, E. C.
Montana, G. S.
Cohen, H. J. |
| TI |
The relationship between older cancer survivors' reports of depression,
anxiety and pain to health providers' findings and mortality. |
| SO |
JOURNAL OF CLINICAL ONCOLOGY |
| SN |
0732-183X |
| PD |
JUN 20 |
| PY |
2006 |
| VL |
24 |
| IS |
18 |
| PN |
Part 1 Suppl. S |
| BP |
492S |
| EP |
492S |
| UT |
ISI:000239009403269 |
| ER |
|
| PT |
J |
| AU |
Pasquini, M
Biondi, M
Costantini, A
Cairoli, F
Ferrarese, G
Picardi, A
Sternberg, C |
| AF |
Pasquini, M.
Biondi, M.
Costantini, A.
Cairoli, F.
Ferrarese, G.
Picardi, A.
Sternberg, C. |
| TI |
Detection and treatment of depressive and anxiety disorders among
cancer patients: Feasibility and preliminary findings from a liaison
service in an oncology division |
| SO |
DEPRESSION AND ANXIETY |
| AB |
Our aim in this observational study was to evaluate the feasibility of
a multiphasic screening project for the detection and treatment of mood
and anxiety disorders among cancer patients in a natural setting. One
hundred sixty-five patients with cancer, consecutively admitted to the
Oncology Division of San Camillo-Forlanini Hospital, were recruited to
the study. All patients had solid tumors; the majority of them were.
colon, breast, and lung cancers. All patients completed the Hospital
Anxiety and Depression Scale (HADS). Patients screened as positive were
administered the following instruments by a psychiatrist. the
Structured Clinical Interview for DSM-IV (SCID-I), the Beck Depression
Inventory (BDI), the Hamilton Anxiety Rating Scale (HARS), and a
validated scale for the rapid dimensional assessment of psychopathology
(SVARAD). The BDI, HARS, and SVARAD were administered again at 4 and 10
weeks to all treated patients. Out of 45 patients administered the
SCID-I, 37 had a mood or anxiety disorder. Adjustment disorders were
identified in 20 patients, depressive disorders in 14, and anxiety
disorders in three patients. Most patients were prescribed psychotropic
medications: mirtazapine was prescribed to 15 patients, citalopram to
13 patients, and escitalopram to four patients. A significant
improvement in symptoms of depression and anxiety was observed on all
measures (P <.001). Although the design of the study prevents any firm
conclusions about effectiveness, this study suggests that including
psychiatric expertise in an oncology division is feasible and may lead
to improved detection and treatment of psychiatric disorders among
cancer patients. Further randomized trials are needed to elaborate on
our findings. |
| SN |
1091-4269 |
| PY |
2006 |
| VL |
23 |
| IS |
7 |
| BP |
441 |
| EP |
448 |
| UT |
ISI:000241907600010 |
| ER |
|
| PT |
J |
| AU |
Cankurtaran, ES
Soygur, AH
Ozalp, E
Turhan, L |
| AF |
Cankurtaran, E. S.
Soygur, A. H.
Ozalp, E.
Turhan, L. |
| TI |
Mirtazapine versus tricyclic antidepressants for the treatment of
depression, anxiety and distressing symptoms of cancer |
| SO |
EUROPEAN NEUROPSYCHOPHARMACOLOGY |
| SN |
0924-977X |
| PD |
SEP |
| PY |
2006 |
| VL |
16 |
| SU |
Suppl. 4 |
| BP |
S324 |
| EP |
S325 |
| UT |
ISI:000240771301022 |
| ER |
|
| PT |
J |
| AU |
Robb, KA
Miles, A
Campbell, J
Evans, P
Wardle, J |
| AF |
Robb, Kathryn A.
Miles, Anne
Campbell, John
Evans, Philip
Wardle, Jane |
| TI |
Can cancer risk information raise awareness without increasing anxiety?
A randomized trial |
| SO |
PREVENTIVE MEDICINE |
| AB |
Objective. Promoting public awareness of cancer risk factors is an
important public health goal, but there is concern that it could
heighten anxiety. This study examined the impact of mailed information
about colorectal cancer on awareness of risk factors, emotional
well-being, and interest in attending screening in a population not
previously exposed to screening.
Method. Individuals (3,185) aged 45-66 years registered with general
practitioners in South-West England in 2004 were randomized to (1)
control group (no information), (2) information on colorectal cancer
risk factors, or (3) information on risk factors and colorectal
screening. All participants were sent a questionnaire assessing
knowledge, anxiety, worry about colorectal cancer, and interest in
screening.
Results. Questionnaires (1,945; 61%) were returned. As expected,
participants receiving information had significantly greater knowledge
than the control group. Anxiety scores were in the normal range and
neither anxiety nor worry about cancer differed significantly between
the groups. Ninety-three percent of respondents indicated they would be
interested in screening, with equally high levels across groups.
Conclusion. This study suggests that information leaflets can promote
knowledge of cancer risk factors without increasing anxiety. Low-cost
educational materials have the potential to contribute to public
engagement with health promotion and disease prevention. (c) 2006
Elsevier Inc. All rights reserved. |
| SN |
0091-7435 |
| PD |
SEP |
| PY |
2006 |
| VL |
43 |
| IS |
3 |
| BP |
187 |
| EP |
190 |
| UT |
ISI:000240876000007 |
| ER |
|
| PT |
J |
| AU |
Antoni, MH
Wimberly, SR
Lechner, SC
Kazi, A
Sifre, T
Urcuyo, KR
Phillips, K
Smith, RG
Petronis, VM
Guellati, S
Wells, KA
Blomberg, B
Carver, CS |
| AF |
Antoni, Michael H.
Wimberly, Sarah R.
Lechner, Suzanne C.
Kazi, Aisha
Sifre, Tammy
Urcuyo, Kenya R.
Phillips, Kristin
Smith, Roselyn G.
Petronis, Vida M.
Guellati, Sophie
Wells, Kurrie A.
Blomberg, Bonnie
Carver, Charles S. |
| TI |
Reduction of cancer-specific thought intrusions and anxiety symptoms
with a stress management intervention among women undergoing treatment
for breast cancer |
| SO |
AMERICAN JOURNAL OF PSYCHIATRY |
| AB |
Objective: After surgery for breast cancer, many women experience
anxiety relating to the cancer that can adversely affect quality of
life and emotional functioning during the year postsurgery. Symptoms
such as intrusive thoughts may be ameliorated during this period with a
structured, group-based cognitive behavior intervention.
Method: A 10-week group cognitive behavior stress management
intervention that included anxiety reduction ( relaxation training),
cognitive restructuring, and coping skills training was tested among
199 women newly treated for stage 0-111 breast cancer. They were then
followed for 1 year after recruitment.
Results: The intervention reduced reports of thought intrusion,
interviewer ratings of anxiety, and emotional distress across 1 year
significantly more than was seen with the control condition. The
beneficial effects were maintained well past the completion of adjuvant
therapy.
Conclusions: Structured, group-based cognitive behavior stress
management may ameliorate cancer-related anxiety during active medical
treatment for breast cancer and for 1 year following treatment.
Group-based cognitive behavior stress management is a clinically useful
adjunct to offer to women treated for breast cancer. |
| SN |
0002-953X |
| PD |
OCT |
| PY |
2006 |
| VL |
163 |
| IS |
10 |
| BP |
1791 |
| EP |
1797 |
| UT |
ISI:000240906800024 |
| ER |
|
| PT |
J |
| AU |
Lienard, A
Merckaert, I
Libert, Y
Delvaux, N
Marchal, S
Boniver, J
Etienne, AM
Klastersky, J
Reynaert, C
Scalliet, P
Slachmuylder, JL
Razavi, D |
| AF |
Lienard, A.
Merckaert, I.
Libert, Y.
Delvaux, N.
Marchal, S.
Boniver, J.
Etienne, A. -M.
Klastersky, J.
Reynaert, C.
Scalliet, P.
Slachmuylder, J. -L.
Razavi, D. |
| TI |
Factors that influence cancer patients' anxiety following a medical
consultation: impact of a communication skills training programme for
physicians |
| SO |
ANNALS OF ONCOLOGY |
| AB |
Background: No study has yet assessed the impact of physicians' skills
acquisition after a communication skills training programme on the
evolution of patients' anxiety following a medical consultation. This
study aimed to compare the impact, on patients' anxiety, of a basic
communication skills training programme (BT) and the same programme
consolidated by consolidation workshops (CW), and to investigate
physicians' communication variables associated with patients' anxiety.
Patients and methods: Physicians, after attending the BT, were randomly
assigned to CW or to a waiting list. The control group was not a
non-intervention group. Consultations with a cancer patient were
recorded. Patients' anxiety was assessed with the State Trait Anxiety
Inventory before and after a consultation. Communication skills were
analysed according to the Cancer Research Campaign Workshop Evaluation
Manual.
Results: No statistically significant change over time and between
groups was observed. Mixed-effects modelling showed that a decrease in
patients' anxiety was linked with screening questions (P = 0.045),
physicians' satisfaction about support given (P = 0.004) and with
patients' distress (P < 0.001). An increase in anxiety was linked with
breaking bad news (P = 0.050) and with supportive skills (P = 0.013).
No impact of the training programme was observed.
Conclusions: This study shows the influence of some communication
skills on the evolution of patients' anxiety. Physicians should be
aware of these influences. |
| SN |
0923-7534 |
| PD |
SEP |
| PY |
2006 |
| VL |
17 |
| IS |
9 |
| BP |
1450 |
| EP |
1458 |
| UT |
ISI:000240587900017 |
| ER |
|
| PT |
J |
| AU |
Osborn, RL
Demoncada, AC
Feuerstein, M |
| AF |
Osborn, Robyn L.
Demoncada, Angelique C.
Feuerstein, Michael |
| TI |
Psychosocial interventions for depression, anxiety, and quality of life
in cancer survivors: Meta-analyses |
| SO |
INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE |
| AB |
Objective: The purpose of this meta-analysis was to investigate the
effects of cognitive behavioral therapy (CBT) and patient education
(PE) on commonly reported problems (depression, anxiety, pain, physical
functioning, and quality of life (QOL)) in adult cancer survivors.
Methods: Meta analyses of randomized controlled trials of CBT and PE
were conducted. MEDLINE, PSYCHINFO and the Cochrane Database were
searched from 1993-2004. The effects of individual versus group
interventions and short (< 8 months) versus long (> 8 months) term
follow up are also reported. Results: Fifteen studies met quality
criteria. The sample size was 1,492 adult cancer survivors with an age
range of 18-84. 790 were randomly assigned to intervention groups and
702 to control groups. CBT varied in duration from 4 weekly one-hour
sessions to 55 weekly two-hour sessions. PE ranged from a single
20-minute session to 6 weekly one-hour sessions. Follow up ranged from
I week to 14 months. CBT was effective for depression (ES = 1.2; 95% Cl
= 0.22-2.19), anxiety (ES = 1.99; 95% Cl = 0.69-3.31), and QOL (ES =
0.91; 95% CI = 0.38-1.44). QOL was improved at both short and (ES =
1.45, 95% CI =.43-2.47) and long term (ES =.26; 95% Cl =.06-.46) follow
up. PE was not related to improved outcomes. Conclusions: CBT is
related to short-term effects on depression and anxiety and both short
and long term effects on QOL. Individual interventions were more
effective than group. Various CBT approaches provided in an individual
format can assist cancer survivors in reducing emotional distress and
improving quality of life. |
| SN |
0091-2174 |
| PY |
2006 |
| VL |
36 |
| IS |
1 |
| BP |
13 |
| EP |
34 |
| UT |
ISI:000239498300002 |
| ER |
|
| PT |
J |
| AU |
Kahan, Z
Varga, K
Dudas, R
Nyari, T
Thurzo, L |
| AF |
Kahan, Zsuzsanna
Varga, Katalin
Dudas, Rita
Nyari, Tibor
Thurzo, Laszlo |
| TI |
Collaborative/active participation per se does not decrease anxiety in
breast cancer |
| SO |
PATHOLOGY & ONCOLOGY RESEARCH |
| AB |
The information needs of breast cancer patients on their disease, its
treatment, the prognosis, and their attitude to decision-making
concerning treatment were assessed. One hundred and fifty early and 45
metastatic breast cancer patients were recruited into the study. The
amount of information and role in the treatment decision-making process
preferred by the patient were independently estimated by the patient
and the oncologist, using questionnaires. Information was provided in
accordance with the wishes of the patient as perceived by the
physician. Test of anxiety was performed before, and one week after the
consultation. Most of the patients claimed to anticipate the provision
of extensive information and an active role in the decision-making, but
real interest during the consultation was found less frequently. The
post-consultation anxiety test revealed a significant decrease in
situational anxiety; this was not related to the patient's information
needs or her attitude to the decision-making concerning treatment. Our
study demonstrates that a significant decrease in anxiety may be
achieved via a consultation tailored to the needs of the patient.
Loading the patient with information and involvement in the decision
regarding therapy as much as the patient seems comfortable with lowers
distress. |
| SN |
1219-4956 |
| PY |
2006 |
| VL |
12 |
| IS |
2 |
| BP |
93 |
| EP |
101 |
| UT |
ISI:000239140500006 |
| ER |
|
| PT |
J |
| AU |
Rogers, SN
Rajlawat, B
Goru, J
Lowe, D
Humphris, GM |
| AF |
Rogers, Simon N.
Rajlawat, Bijaya
Goru, Janaki
Lowe, Derek
Humphris, Gerry M. |
| TI |
Comparison of the domains of anxiety and mood of the University of
Washington Head and Neck Cancer Questionnaire (UW-QOL v4) with the
CES-D and HADS |
| SO |
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND
NECK |
| AB |
Background. Version 4 of the University of Washington Head and Neck
Cancer Questionnaire (UW-QOLv4) includes items on mood and anxiety. The
aim of this study was to compare the responses to these single items
with the Centre for Epidemiology Studies Depression Scale (CES-D) and
the Hospital Anxiety Depression Scale (HADS).
Methods. A cross-sectional postal survey was undertaken in April 2003.
The survey was composed of all patients treated for oral and
oropharyngeal squamous cell carcinoma between 1992 and 2002 who were
alive and disease free.
Results. We distributed 306 questionnaires; there were 197 replies
(65%) from 110 male and 87 female patients. Most patients reported
relatively little depression, with 170 of 190 (89%) reporting a HADS
depression score of less than 11. Similarly, most patients were not
anxious, with 158 of 183 (86%) reporting a HADS anxiety score of less
than 11. UW-QOL mood, UW-QOL anxiety, HADS anxiety, HADS depression,
and CES-D scores were all moderately intercorrelated (Spearman
correlations from 0.39-0.68 ignoring the signs, all p < .001). The
UW-COIL mood correlated with the scores and "case-ness" categories of
the HADS depression and CES-D scales, whereas the UW-QOL anxiety
correlated with the scores and "case-ness" of the HADS anxiety.
Conclusions. Questions on mood and anxiety can help identify
significant psychological 'morbidity, taking a score of less than 75
for UW-QOL mood and less than 70 for UW-OOL anxiety. This could be used
to trigger formal psychological assessment and with a view to possible
therapeutic intervention. (c) 2006 Wiley Periodicals, Inc. |
| SN |
1043-3074 |
| PD |
AUG |
| PY |
2006 |
| VL |
28 |
| IS |
8 |
| BP |
697 |
| EP |
704 |
| UT |
ISI:000239179900005 |
| ER |
|
| PT |
J |
| AU |
Roth, A
Nelson, CJ
Rosenfeld, B
Warshowski, A
O'Shea, N
Scher, H
Holland, JC
Slovin, S
Curley-Smart, T
Reynolds, T
Breitbart, W |
| TI |
Assessing anxiety in men with prostate cancer: Further data on the
reliability and validity of the Memorial Anxiety Scale for Prostate
Cancer (MAX-PC) |
| SO |
PSYCHOSOMATICS |
| AB |
Identifying which men with prostate cancer might benefit from mental
health treatment has proven to be a challenging task. The authors
developed the Memorial Anxiety Scale for Prostate Cancer (MAX-PC) in
order to facilitate the identification of prostate cancer-related
anxiety. A revised version of this scale was tested in a more
clinically varied population. Ambulatory men with prostate cancer (N =
367) completed a baseline assessment packet that included the MAXPC and
other psychosocial questionnaires. The MAX-PC showed high internal
consistency and concurrent and discriminant validity. Factor analysis
identified three distinct factors for the MAX-PC that corresponded to
the intended subscales (General Prostate Cancer Anxiety, PSA
(prostate-specific antigen) Anxiety, and Fear of Recurrence). PSA
levels were not correlated with anxiety overall; however, anxiety was
significantly higher among patients whose PSA levels were changing
(i.e., rising, falling, and unstable), versus those with stable PSA
levels. Also, in a multivariate analysis, the change in PSA levels was
a significant predictor of MAX-PC scores, but not Hospital Anxiety and
Depression Scale (HADS) scores. These results indicate that the MAX-PC
is a valid and reliable measure of anxiety that assesses aspects of
anxiety unique to men with prostate cancer and it may provide a more
sensitive measure of anxiety than the HADS for this population. |
| SN |
0033-3182 |
| PD |
JUL-AUG |
| PY |
2006 |
| VL |
47 |
| IS |
4 |
| BP |
340 |
| EP |
347 |
| UT |
ISI:000238767900011 |
| ER |
|
| PT |
J |
| AU |
Tagay, S
Herpertz, S
Langkafel, M
Erim, Y
Bockisch, A
Senf, W
Gorges, R |
| TI |
Health-related quality of life, depression and anxiety in thyroid
cancer patients |
| SO |
QUALITY OF LIFE RESEARCH |
| AB |
Objectives: We examined the relationships among physical complaints,
health-related quality of life (HRQL), anxiety and depression in
differentiated thyroid cancer (DTC) patients under short-term
hypothyroidism.
Methods: We conducted a cross-sectional study in 136 patients
hypothyroid on thyroid hormone withdrawal (THW) hospitalized for
radioiodine administration. Patients were assessed using Short Form
SF-36 (SF-36), Hospital Anxiety and Depression Scale (HADS), Profile of
Mood States (POMS), Beck Depression Inventory (BDI), and physical
complaints.
Results: Compared to the German general population, hypothyroid
patients had significantly impaired HRQL. Surprisingly, the prevalence
of anxiety (62.5%), but not depression (17.9%) was much higher in
hypothyroid DTC patients than in the general population. In
multivariate analysis, depression and age were independently associated
with the physical health score (R-2 = 0.21), but only psychological
variables (depression, mood disturbance, and anxiety) were associated
with the mental health score (R-2 = 0.43), on the SF-36 HRQL instrument.
Conclusions: HRQL is severely impaired in DTC patients under short-term
hypothyroidism. As potential predictors of generic HRQL impairment,
depression, anxiety, and mood disturbance could be used to preselect
the patients most needing psychiatric care. The high frequency of
anxiety should be considered in the aftercare of thyroid cancer
patients. |
| SN |
0962-9343 |
| PD |
MAY |
| PY |
2006 |
| VL |
15 |
| IS |
4 |
| BP |
695 |
| EP |
703 |
| UT |
ISI:000237489100012 |
| ER |
|
| PT |
J |
| AU |
Hedstrom, M
Kreuger, A
Ljungman, G
Nygren, P
von Essen, L |
| TI |
Accuracy of assessment of distress, anxiety, and depression by
physicians and nurses in adolescents recently diagnosed with cancer |
| SO |
PEDIATRIC BLOOD & CANCER |
| AB |
Background. As staff members prioritize medical resources for patients,
it is imperative to find Out whether their assessments of patients'
health status agree with patients' assessments. The degree to which
physicians and nurses can identify the distress, anxiety, and
depression experienced by adolescents recently diagnosed with cancer
was examined here. Procedure. Adolescents undergoing chemotherapy
(13-19 years, n = 53), physicians (n 48), and nurses (n=53) completed a
structured telephone interview, 4-8 weeks after diagnosis or relapse,
investigating disease and treatment-related distress, anxiety, and
depression. Results. The accuracy of staff ratings of physical distress
could be considered acceptable. However, problems of a psychosocial
nature, which were frequently overestimated, were difficult for staff
to identify. Staff underestimated the distress caused by mucositis and
worry about missing school more than they overestimated distress. These
aspects were some of the most prevalent and overall worst according to
the adolescents. Both physicians and nurses overestimated levels of
anxiety and depression. Nurses tended to show higher sensitivity than
physicians for distress related to psychosocial aspects of distress,
while physicians tended to show higher accuracy than nurses for
physical distress. Conclusions. Staff was reasonably accurate at
identifying physical distress in adolescents recently diagnosed with
cancer whereas psychosocial problems were generally poorly identified.
Thus, the use of staff ratings as a "test" to guide specific Support
seems problematic. Considering that the accuracy of staff ratings
outside a research study is probably lower, identification of and
action taken on adolescent problems in relation to cancer diagnosis and
treatment need to rely on direct communication. |
| SN |
1545-5009 |
| PD |
JUN |
| PY |
2006 |
| VL |
46 |
| IS |
7 |
| BP |
773 |
| EP |
779 |
| UT |
ISI:000237304100013 |
| ER |
|
| PT |
J |
| AU |
Norberg, AL
Lindblad, F
Boman, KK |
| TI |
Support-seeking, perceived support, and anxiety in mothers and fathers
after children's cancer treatment |
| SO |
PSYCHO-ONCOLOGY |
| AB |
The objective was to examine the relationships between anxiety, the
seeking of social support as a coping strategy, and perceived social
support among mothers (n = 103) and fathers (n = 8 1) of children with
successfully completed treatment for cancer. Assessments were done
using self-report instruments. The mediating effect of perceived
support on the relationship between social support-seeking and anxiety
was evaluated through path analysis, and comparisons were done in order
to evaluate effects of gender.
For mothers and fathers alike, a positive relationship of moderate
strength between support-seeking and perceived support was found.
Anxiety was negatively related to support-seeking (mothers r = -0.22, p
= 0.025; fathers r = -0.21, p = 0.063) as well as perceived support
(mothers r = -0.55, p < 0.001; fathers r = -0.41 p < 0.001), although
the relationship for support-seeking was weak. The path analysis showed
that perceived support only to a minor extent could strengthen this
association. The significance of support-seeking and perceived support
was stronger for mothers than for fathers, as regards their association
with anxiety. However, the patterns of interrelations were similar for
mothers and fathers. In conclusion, parents' subjectively perceived
support appears to be more important for anxiety regulation than their
support-seeking coping. In clinical practice, individual variation
should be acknowledged, and presumptions of general gender differences
avoided. Copyright (c) 2005 John Wiley & Sons, Ltd. |
| SN |
1057-9249 |
| PD |
APR |
| PY |
2006 |
| VL |
15 |
| IS |
4 |
| BP |
335 |
| EP |
343 |
| UT |
ISI:000236993400006 |
| ER |
|
| PT |
J |
| AU |
Jones, RB
Pearson, J
Cawsey, AJ
Bental, D
Barrett, A
White, J
White, CA
Gilmour, WH |
| TI |
Effect of different forms of information produced for cancer patients
on their use of the information, social support, and anxiety:
randomised trial |
| SO |
BRITISH MEDICAL JOURNAL |
| AB |
Objective To explore the hypothesis that different methods of selecting
and printing information for cancer patients could improve emotional
support by affecting interaction with others, and so lead to improved
psychological wellbeing.
Design Randomised trial with eight groups (three factors, 2x2x2). Data
collected at recruitment and three month follow-up.
Participants 400 patients starting radiotherapy, Of whom 325 with
breast or prostate cancer and complete anxiety and depression data were
included in the analysis.
Interventions Printed booklets: half had only general information from
CancerBACUP about each patients cancer and half had personalised
information from the patient's medical record plus selected general
information; half were composed of information chosen interactively by
the patient and half were produced automatically with a larger volume
of material; mid half had additional advice on anxiety management.
Main outcome measures Patients' views of the information, use of their
booklets with others; change in reported social support; change in
anxiety and depression.
Results The larger booklets produced automatically were more likely to
be found useful and to tell patients something new and less likely to
be seen as too limited than the booklets produced interactively, but
they were also more likely to overwhelm some patients. Personalised
booklets were more likely than general booklets to tell patients
something new. There was no difference in patients' perceived
understanding of their cancer by any of the intervention factors.
Patients with personalised information were more likely to show their
booklets to others and to think it helped in discussing their, cancer
or its treatment. There were no major differences in social support,
anxiety, or depression by an), intervention factors.
Conclusions Patients were more likely to show personalised information
to their confidants than general information. Further research is
needed into the effects of sharing information on patients' social
Support and anxiety. |
| SN |
0959-8146 |
| PD |
APR 22 |
| PY |
2006 |
| VL |
332 |
| IS |
7547 |
| BP |
942 |
| EP |
946A |
| UT |
ISI:000237143900016 |
| ER |
|
| PT |
J |
| AU |
McCoubrie, R
Davies, A |
| TI |
Is there a correlation between spirituality and anxiety and depression
in patients with advanced cancer? |
| SO |
SUPPORTIVE CARE IN CANCER |
| AB |
Aims and objectives: To establish whether there is a correlation
between spirituality and anxiety and depression in patients with
advanced cancer. Patients and methods: Patients with a diagnosis of
cancer at St. Peter's day hospice in Bristol were asked to complete
three questionnaires to assess anxiety, depression and spirituality.
Informed consent was obtained. Anxiety and depression are indicated by
the Hospital Anxiety and Depression Scale score, and spirituality is
indicated by scores on the Spiritual Well-Being Scale (SWBS) and the
Royal Free Interview for Spiritual and Religious Beliefs. As will be
explained, religion and spirituality are generally recognised as having
different meanings-religion entailing a relationship with a higher
being, while spirituality can be thought of in terms of meaning and
purpose in life. Results: Eighty-five complete data sets were obtained.
A significant negative correlation was found between both anxiety and
depression scores and overall spiritual well-being scores (p < 0.0001).
When the SWBS subscale scores were analysed individually, a significant
negative correlation was found between the existential well-being
scores and the anxiety and depression scores (p < 0.001). However, no
correlation was found between the religious well-being scores and
anxiety or depression. Conclusions: This study found a significant
negative correlation between spirituality (in particular, the
existential aspect) and anxiety and depression in patients with
advanced cancer. Religious well-being and strength of belief had no
impact on psychological well-being in this study. |
| SN |
0941-4355 |
| PD |
APR |
| PY |
2006 |
| VL |
14 |
| IS |
4 |
| BP |
379 |
| EP |
385 |
| UT |
ISI:000236983200012 |
| ER |
|
| PT |
J |
| AU |
Korfage, IJ
Esskink-Bot, ML
Janssens, ACJW
Schroder, FH
de Koning, HJ |
| TI |
Anxiety and depression after prostate cancer diagnosis and treatment:
5-year follow-up |
| SO |
BRITISH JOURNAL OF CANCER |
| AB |
To document anxiety and depression from pretreatment till 5-year
follow-up in 299 men with localized prostate cancer. To assess, if
baseline scores were predictive for anxiety and depression at 1-year
follow-up. Respondents completed four assessments (pretreatment, at 6
and 12 months, and at 5-year follow-up) on anxiety, depression and
mental health. Respondents were subdivided according to therapy
(prostatectomy or radiotherapy) and high vs low-anxiety. Pretreatment
28% of all patients were classified as 'high-anxiety'; their average
anxiety scores decreased significantly post-treatment, that is towards
less anxiety. At all assessments, high-anxiety men treated by
prostatectomy reported less depression than high-anxiety men treated by
radiotherapy. Of men treated by radiotherapy, 27% reported clinical
significant levels of depression while 20% is expected in a general
population. The improvement in mental health at 6-months follow-up was
statistically significant and clinically meaningful in all respondent
groups. Sensitivity of anxiety at baseline as a screening tool was 71%
for anxiety and 60% for symptoms of depression. We recommend clinicians
to attempt early detection of patients at risk of high levels of
anxiety and depression after prostate cancer diagnosis since prevalence
is high. STAI-State can be a useful screening tool but needs further
development. |
| SN |
0007-0920 |
| PD |
APR 24 |
| PY |
2006 |
| VL |
94 |
| IS |
8 |
| BP |
1093 |
| EP |
1098 |
| UT |
ISI:000236910300002 |
| ER |
|
| PT |
J |
| AU |
Rimes, KA
Salkovskis, PA
Jones, L
Lucassen, AA |
| TI |
Applying a cognitive-behavioral model of health anxiety in a cancer
genetics service |
| SO |
HEALTH PSYCHOLOGY |
| AB |
A cognitive-behavioral model of health anxiety was used to investigate
reactions to genetic counseling for cancer. Participants (N = 218) were
asked to complete a questionnaire beforehand and 6 months later. There
was an overall decrease in levels of cancer-related anxiety, although
24% of participants showed increased cancer-related anxiety at
follow-up. People who had a general tendency to worry about their
health reported more cancer-related anxiety than those who did not at
both time points. This health-anxious group also showed a
postcounseling anxiety reduction, whereas the others showed no
significant change. Participants with breast or ovarian cancer in their
family were more anxious than participants with colon cancer in their
family. Preexisting beliefs were significant predictors of anxiety,
consistent with a cognitive-behavioral approach. |
| SN |
0278-6133 |
| PD |
MAR |
| PY |
2006 |
| VL |
25 |
| IS |
2 |
| BP |
171 |
| EP |
180 |
| UT |
ISI:000236681200005 |
| ER |
|
| PT |
J |
| AU |
Saevarsdottir, T
Fridriksdottir, N
Gunnarsdottir, S |
| TI |
Quality of life, symptoms of anxiety and depression, and rehabilitation
needs of people receiving chemotherapy for cancer at the initiation of
chemotherapy and three months later. |
| SO |
ONCOLOGY NURSING FORUM |
| SN |
0190-535X |
| PD |
MAR |
| PY |
2006 |
| VL |
33 |
| IS |
2 |
| BP |
469 |
| EP |
469 |
| UT |
ISI:000236697600285 |
| ER |
|
| PT |
J |
| AU |
[Anon] |
| TI |
Trait anxiety predicts fatigue in women with early stage breast cancer |
| SO |
EJC SUPPLEMENTS |
| SN |
1359-6349 |
| PD |
MAR |
| PY |
2006 |
| VL |
4 |
| IS |
2 |
| BP |
91 |
| EP |
92 |
| UT |
ISI:000236447700183 |
| ER |
|
| PT |
J |
| AU |
Mehnert, A
Cao, P
Graefen, M
Huland, H
Koch, U |
| TI |
Prevalence of post-traumatic stress disorder, anxiety and depression in
patients with prostate cancer |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
FEB |
| PY |
2006 |
| VL |
15 |
| IS |
1 |
| SU |
Suppl. S |
| BP |
S66 |
| EP |
S66 |
| UT |
ISI:000235659000125 |
| ER |
|
| PT |
J |
| AU |
Greer, JA
Zhang, BH
Vanderwerker, LC
Prigerson, HG |
| TI |
Prevalence and correlates of anxiety in patients with advanced cancer |
| SO |
PSYCHO-ONCOLOGY |
| SN |
1057-9249 |
| PD |
FEB |
| PY |
2006 |
| VL |
15 |
| IS |
1 |
| SU |
Suppl. S |
| BP |
S81 |
| EP |
S82 |
| UT |
ISI:000235659000152 |
| ER |
|
| PT |
J |
| AU |
Thomas, BC
Devi, N
Sarita, GP
Rita, K
Ramdas, K
Hussain, BM
Rejnish, R
Pandey, M |
| TI |
Reliability & validity of the Malayalam hospital anxiety & depression
scale (HADS) in cancer patients |
| SO |
INDIAN JOURNAL OF MEDICAL RESEARCH |
| AB |
Background & objectives: The hospital anxiety and depression scale
(HADS) has been widely used on cancer patients as an indicator of
psychological morbidity. Though the scale has been used in India, no
reports are available on translation of HADS in any Indian language and
testing the reliability. The present study describes the translation
process of HADS into Malayalam and testing its reliability and validity
on psychological morbidity in cancer patients.
Methods: The English version of the HADS was translated into Malayalam
and was used in this study. The questionnaire was administered to 240
cancer patients and statistical analysis was carried out using
Chronbach's alpha to test the internal consistancy of the HADS scale
while confirmatory factor analysis was carried out using principal axis
factoring with equimax rotation and Kaiser Normalization to test its
construct validity.
Results: The Cronbach's alpha was found to be 0.81 for the HADS anxiety
subscale, 0.71 for the BADS depression subscale, and 0.85 for RADS
tool. Confirmatory factor analysis (CFA) indicated two depression items
(i.e., enjoyment and anhedonia) loading onto the anxiety subscale.
Clinical caseness for anxiety was observed in 8 per cent, while 11 per
cent of the patients had borderline mood disorder. Clinical caseness
for depression was identified in 7.6 and 13 per cent of patients were
found to have borderline mood disturbances.
Interpretation & conclusion: This preliminary validation study of the
Malayalam version of the HADS showed it as an acceptable, and reliable
measure of psychological morbidity among cancer patients. The
prevalence of anxiety and depression in Indian population was low and
enjoyment and anhedonia might present as anxiety initially. |
| SN |
0971-5916 |
| PD |
NOV |
| PY |
2005 |
| VL |
122 |
| IS |
5 |
| BP |
395 |
| EP |
399 |
| UT |
ISI:000235017900007 |
| ER |
|
| PT |
J |
| AU |
Tagay, S
Herpertz, S
Langkafel, M
Erim, Y
Freudenberg, L
Schopper, N
Bockisch, A
Senf, W
Gorges, R |
| TI |
Health-related quality of life, anxiety and depression in thyroid
cancer patients under short-term hypothyroidism and TSH-suppressive
levothyroxine treatment |
| SO |
EUROPEAN JOURNAL OF ENDOCRINOLOGY |
| AB |
Objective: Very few previous studies have compared the degree of
health-related quality of life (HRQL), depression and anxiety of
differentiated thyroid cancer patients (DTC) under short-term
hypothyroidism and levothyroxine treatment.
Methods: Using patient-completed instruments, we examined the frequency
of physical complaints, HRQL, anxiety and depression in 130 DTC
patients hospitalized for radioiodine therapy or whole-body diagnostics
(age 52 years, female 71%) under short-term hypothyroidism (4 weeks of
levothyroxine withdrawal; DTC-H) and in 100 DTC out-patients under
TSH-suppressive doses of levothyroxine subsequent to radioiodine
therapy (DTC-L; age 49 years, female 81%).
Results: Compared with the German general population, DTC-H as well as
DTC-L patients had significantly impaired HRQL. Notably, the decrease
in HRQL was significantly higher in DTC-H than in DTC-L patients.
Surprisingly, the prevalence of anxiety (44.6%) but not depression
(17.7%) was much higher in the DTC-H patients than in the general
population. In contrast to expectations, similar results for anxiety
(44.0%) and depression (17.6%) were observed in the DTC-L patients.
Conclusions: This mounting evidence suggests that a consistent pattern
of HRQL impairment is experienced by patients with DTC. The high
frequency of anxiety and the significantly reduced HRQL should be
considered in the aftercare of DTC patients. |
| SN |
0804-4643 |
| PD |
DEC |
| PY |
2005 |
| VL |
153 |
| IS |
6 |
| BP |
755 |
| EP |
763 |
| UT |
ISI:000234216100005 |
| ER |
|
| PT |
J |
| AU |
Gothelf, D
Rubinstein, M
Shemesh, E
Miller, O
Farbstein, I
Klein, A
Weizman, A
Apter, A
Yaniv, I |
| TI |
Pilot study: Fluvoxamine treatment for depression and anxiety disorders
in children and adolescents with cancer |
| SO |
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY |
| AB |
Objective: To evaluate the safety, tolerability, and benefit of
fluvoxamine for the treatment of major depressive disorder or anxiety
disorders in children and adolescents with cancer. Method: The study
was conducted from 2001 to 2004 at a pediatric hematology-oncology
center. Fifteen children and adolescents with cancer were treated with
fluvoxamine 100 mg/day in an open prospective 8-week trial. Safety and
tolerability were evaluated at baseline and at weeks 4 and 8 by blood
tests and the Side Effects Checklist. Clinical benefit was assessed
with the Clinical Global ImpressionsImprovement, the Children's
Depression Rating Scale-Revised, and the Pediatric Anxiety Rating
Scale. Results: Fluvoxamine was well tolerated by all subjects.
Psychiatric symptoms improved significantly. Conclusions: In this open
trial, fluvoxamine appeared to be well tolerated and was associated
with a promising reduction in the depression and anxiety symptoms of
pediatric patients with cancer. |
| SN |
0890-8567 |
| PD |
DEC |
| PY |
2005 |
| VL |
44 |
| IS |
12 |
| BP |
1258 |
| EP |
1262 |
| UT |
ISI:000233470000007 |
| ER |
|
| PT |
J |
| AU |
Bez, Y
Topcuoglu, V
Kemal, KM
Demir, A
Turkeri, L |
| TI |
Comparison of depression, anxiety and quality of life in prostate
cancer patients with and without sexual dysfunctions |
| SO |
JOURNAL OF PSYCHOSOMATIC RESEARCH |
| SN |
0022-3999 |
| PD |
JUL |
| PY |
2005 |
| VL |
59 |
| IS |
1 |
| BP |
23 |
| EP |
24 |
| UT |
ISI:000232433800011 |
| ER |
|
| PT |
J |
| AU |
Ozkan, M
Kurt, A |
| TI |
The comparison of anxiety and depression in patients with cancer pain
and non-cancer chronic pain |
| SO |
JOURNAL OF PSYCHOSOMATIC RESEARCH |
| SN |
0022-3999 |
| PD |
JUL |
| PY |
2005 |
| VL |
59 |
| IS |
1 |
| BP |
42 |
| EP |
42 |
| UT |
ISI:000232433800084 |
| ER |
|
| PT |
J |
| AU |
Ozkan, S
Sipahi, B |
| TI |
Evaluation of anxiety, depression expressive motions of mothers with
children who has cancer from a psychosocial perspective |
| SO |
JOURNAL OF PSYCHOSOMATIC RESEARCH |
| SN |
0022-3999 |
| PD |
JUL |
| PY |
2005 |
| VL |
59 |
| IS |
1 |
| BP |
43 |
| EP |
43 |
| UT |
ISI:000232433800086 |
| ER |
|
| PT |
J |
| AU |
Monti, DA
Mago, R
Kunkel, EJS |
| TI |
Depression, cognition, and anxiety among postmenopausal women with
breast cancer |
| SO |
PSYCHIATRIC SERVICES |
| SN |
1075-2730 |
| PD |
NOV |
| PY |
2005 |
| VL |
56 |
| IS |
11 |
| BP |
1353 |
| EP |
1355 |
| UT |
ISI:000233118200004 |
| ER |
|
| PT |
J |
| AU |
Asanami, C
Tei, K
Totsuka, Y
Katakura, A
Shibahara, T
Ueda, M
Yamashita, T
N |
|
